ATE214069T1 - Heterocyclische verbindungen und ihre herstellung und verwendung - Google Patents

Heterocyclische verbindungen und ihre herstellung und verwendung

Info

Publication number: ATE214069T1
Authority: AT; Austria
Prior art keywords: independently; image; alkoxy; optionally substituted; alkyl
Prior art date: 1994-02-11

Application number

AT95909651T

Other languages

English (en)

Inventor

Lone Jeppesen

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-02-11

Filing date

1995-01-30

Publication date

2002-03-15

1995-01-30 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2002-03-15 Application granted granted Critical

2002-03-15 Publication of ATE214069T1 publication Critical patent/ATE214069T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Endocrinology (AREA)
Obesity (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Plural Heterocyclic Compounds (AREA)

AT95909651T 1994-02-11 1995-01-30 Heterocyclische verbindungen und ihre herstellung und verwendung ATE214069T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DK18394		1994-02-11
DK135194		1994-11-25
PCT/DK1995/000044 WO1995021842A1 (en)	1994-02-11	1995-01-30	Heterocyclic compounds and their preparation and use

Publications (1)

Publication Number	Publication Date
ATE214069T1 true ATE214069T1 (de)	2002-03-15

Family

ID=26063483

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95909651T ATE214069T1 (de)	1994-02-11	1995-01-30	Heterocyclische verbindungen und ihre herstellung und verwendung

Country Status (15)

Country	Link
US (1)	US5741785A (de)
EP (1)	EP0743945B1 (de)
JP (1)	JPH09508632A (de)
KR (1)	KR970701192A (de)
CN (1)	CN1045964C (de)
AT (1)	ATE214069T1 (de)
AU (1)	AU692524B2 (de)
CA (1)	CA2182957A1 (de)
DE (1)	DE69525738D1 (de)
FI (1)	FI963130L (de)
HU (1)	HUT76323A (de)
IL (1)	IL112588A (de)
NO (1)	NO306781B1 (de)
NZ (1)	NZ281183A (de)
WO (1)	WO1995021842A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH10513435A (ja) *	1994-09-30	1998-12-22	ビーエーエスエフアクチェンゲゼルシャフト	複素環で置換された新規イミダゾロキノキサリノン、その製造および使用
FR2743363A1 (fr) *	1996-01-10	1997-07-11	Rhone Poulenc Rorer Sa	5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant
DE19611476A1 (de) *	1996-03-22	1997-09-25	Basf Ag	Neue heterocyclische substituierte Imidazolo-chinoxalinone, ihre Herstellung und Verwendung
IL125950A0 (en) *	1997-09-05	1999-04-11	Pfizer Prod Inc	Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
ES2599054T3 (es) *	2006-12-13	2017-01-31	Aska Pharmaceutical Co., Ltd.	Derivados de quinoxalina
EP2114948B1 (de) *	2006-12-28	2014-06-25	AbbVie Inc.	Inhibitoren von poly(adp-ribose)polymerase
EP4403185A4 (de)	2021-09-15	2025-10-08	Univ Of The Ryukyus	Pharmazeutische zusammensetzung zur behandlung von kognitivem verfall oder zur behandlung von übergewicht oder adipositas
US20240398775A1 (en)	2021-09-15	2024-12-05	University Of The Ryukyus	Pharmaceutical composition for use in treating cognitive decline or for use in treating overweight or obesity

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2448541A1 (fr) *	1979-02-09	1980-09-05	Roussel Uclaf	Nouveaux derives de l'oxoimidazoquinoxaline et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
GB2043637B (en) *	1979-02-09	1983-03-16	Roussel Lab Ltd	Heterotricyclic derivatives
GB2043064B (en) *	1979-02-09	1983-04-13	Roussel Lab Ltd	Oximidazoquinoxaline derivatives
US5055465A (en) *	1989-05-31	1991-10-08	Berlex Laboratories, Inc.	Imidazoquinoxalinones, their aza analogs and process for their preparation
US5153196A (en) *	1991-06-05	1992-10-06	Eli Lilly And Company	Excitatory amino acid receptor antagonists and methods for the use thereof
US5182386A (en) *	1991-08-27	1993-01-26	Neurogen Corporation	Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands
WO1993020077A1 (fr) *	1992-04-03	1993-10-14	Yamanouchi Pharmaceutical Co., Ltd.	Derive de quinoxalinone fondue et composition pharmaceutique le contenant
DE4329970A1 (de) *	1993-03-31	1994-10-06	Basf Ag	Neue Imidazolo-chinoxalinone, ihre Hestellung und Verwendung
DE4310523A1 (de) *	1993-03-31	1994-10-06	Basf Ag	Imidazolo-chinoxalinone zur Behandlung zentralnervöser Erkrankungen
EP0691970B1 (de) *	1993-03-31	1998-11-11	Basf Aktiengesellschaft	Imidazolochinoxalinonderivate als eaa antagonisten

1995
- 1995-01-30 FI FI963130A patent/FI963130L/fi unknown
- 1995-01-30 CN CN95192360A patent/CN1045964C/zh not_active Expired - Fee Related
- 1995-01-30 NZ NZ281183A patent/NZ281183A/en unknown
- 1995-01-30 DE DE69525738T patent/DE69525738D1/de not_active Expired - Fee Related
- 1995-01-30 AU AU18055/95A patent/AU692524B2/en not_active Ceased
- 1995-01-30 EP EP95909651A patent/EP0743945B1/de not_active Expired - Lifetime
- 1995-01-30 HU HU9602203A patent/HUT76323A/hu unknown
- 1995-01-30 JP JP7520915A patent/JPH09508632A/ja not_active Ceased
- 1995-01-30 WO PCT/DK1995/000044 patent/WO1995021842A1/en not_active Ceased
- 1995-01-30 KR KR1019960704332A patent/KR970701192A/ko not_active Ceased
- 1995-01-30 CA CA002182957A patent/CA2182957A1/en not_active Abandoned
- 1995-01-30 AT AT95909651T patent/ATE214069T1/de not_active IP Right Cessation
- 1995-02-08 US US08/385,250 patent/US5741785A/en not_active Expired - Fee Related
- 1995-02-09 IL IL11258895A patent/IL112588A/xx not_active IP Right Cessation
1996
- 1996-08-09 NO NO963337A patent/NO306781B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR970701192A (ko)	1997-03-17
FI963130A7 (fi)	1996-10-09
JPH09508632A (ja)	1997-09-02
CA2182957A1 (en)	1995-08-17
AU1805595A (en)	1995-08-29
US5741785A (en)	1998-04-21
CN1045964C (zh)	1999-10-27
HU9602203D0 (en)	1996-10-28
DE69525738D1 (de)	2002-04-11
FI963130L (fi)	1996-10-09
NZ281183A (en)	1998-05-27
NO963337D0 (no)	1996-08-09
NO306781B1 (no)	1999-12-20
WO1995021842A1 (en)	1995-08-17
AU692524B2 (en)	1998-06-11
NO963337L (no)	1996-10-11
IL112588A0 (en)	1995-05-26
CN1145071A (zh)	1997-03-12
IL112588A (en)	1999-07-14
EP0743945A1 (de)	1996-11-27
HUT76323A (en)	1997-08-28
EP0743945B1 (de)	2002-03-06
FI963130A0 (fi)	1996-08-09

Publication	Publication Date	Title
ATE116317T1 (de)	1995-01-15	Chinuclidinderivate.
ATE207064T1 (de)	2001-11-15	Benzodiazepinderivate
YU85001A (sh)	2004-09-03	Derivati 5-fenil-pirimidina
TW377354B (en)	1999-12-21	[1,2,4]triazolo[4,3-a]quinoxaline compounds, their preparation and use
DE69525738D1 (de)	2002-04-11	Heterocyclische verbindungen und ihre herstellung und verwendung
DE69509888D1 (de)	1999-07-01	IMIDAZO[1,2-a]INDENO [1,2-e] PYRAZINONE ANTAGONISTEN DER AMPA UND NMDA REZEPTOREN
TR199900096T2 (xx)	1999-03-22	Bradykinin B2 antagonistleri olarak elveri�li N-benzensulfonil-L-prolin t�revleri.
ATE102626T1 (de)	1994-03-15	Heterocyclische verbindungen, ihre darstellung und verwendung.
NO305439B1 (no)	1999-05-31	Pyrido(1,2,3-de)kinoksalinderivater og legemidler inneholdende disse
MX9703671A (es)	1997-12-31	Compuesto de aminometil arilo y ligandos selectivos del subtipo de receptor de la dopamina.

Legal Events

Date	Code	Title	Description
2002-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties